Cipher Pharmaceuticals (PHE) Stock Forecast & Price Target
PHE Analyst Ratings
PHE Stock 12 Month Forecast
Average Price Target
EUR 12.75▲(57.41% Upside)Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Justin Keywood | Stifel Nicolaus | EUR 12.75 | buy | 57.41%Upside | Reiterated | 09/23/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Justin Keywood | 09/23/26 | EUR 12.75 | buy | 57.41%Upside | Reiterated | Stifel Nicolaus |
Best Analysts Covering Cipher Pharmaceuticals
Copying Justin Keywood's trades and holding each position for 3 Months would result in 38.10% of your transactions generating a profit, with an average return of -1.48% per trade.
Copying Justin Keywood's trades and holding each position for 1 Year would result in 47.62% of your transactions generating a profit, with an average return of +11.04% per trade.
Copying Justin Keywood's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +4.40% per trade.
PHE Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 2 | 2 | 3 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 2 | 2 | 3 | 2 |
In the current month, PHE has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. PHE average Analyst price target in the past 3 months is 12.75.
PHE Financial Forecast
PHE Earnings Forecast
Next quarter’s earnings estimate for PHE is EUR 0.18 with a range of EUR 0.10 to EUR 0.24. The previous quarter’s EPS was EUR 0.13. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
PHE Sales Forecast
Next quarter’s sales forecast for PHE is EUR 10.91M with a range of EUR 8.41M to EUR 11.96M. The previous quarter’s sales results were EUR 10.67M. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.